The Oncology Connection

What is Good Cancer Care?

Bo Gamble - Community Oncology Alliance (COA) & Ronda Bowman - ASCO Care Delivery Bo Gamble - Community Oncology Alliance (COA) & Ronda Bowman - ASCO Care Delivery

Bo Gamble, Director of Quality and Value - Community Oncology Alliance (COA)

Read more

Does smoking cessation help patients with lung cancer live longer?

Shiying Huang, RN, Nurse Practitioner student Shiying Huang, RN, Nurse Practitioner student

Thanks to advancements of cancer treatments, the cancer death rate has decreased 23% from 1999 to 2019 in the United States. Nevertheless, lung cancer remains the leading cause of cancer death in 2022 in the United States. In patients with non-small cell lung cancer (NSCLC), the 5-year survival ...

Read more

Self-Care in the Workplace: Much Needed but Often Neglected

Anna Poullard DNP, ACNP-BC* & Sheena Charles MS, FNP-BC* Anna Poullard DNP, ACNP-BC* & Sheena Charles MS, FNP-BC*

*Department of Investigational Cancer Therapeutics

Read more

ST Elevation in a Patient Enrolled in an Anti-CD40 Monoclonal Antibody Phase I Clinical Trial

Fedricker D. Barber, PhD, ANP-BC, AOCNP, FAANP, FAAN and Myrshia L. Woods, MHS, PA-C Fedricker D. Barber, PhD, ANP-BC, AOCNP, FAANP, FAAN and Myrshia L. Woods, MHS, PA-C

A Case of ST Elevation in a Patient Enrolled in an Anti-CD40 Monoclonal Antibody Phase I Clinical Trial

Read more

Should we be worried about immunotherapy efficacy in patients taking antibiotics and PPI’s?

Beth Sandy, MSN, CRNP Beth Sandy, MSN, CRNP

Proton pump inhibitors (PPI’s) are very common to use in a wide variety of patients to treat many different symptoms of anything from a more serious condition like Barrett’s Esophagus down to a self-diagnosed heartburn. Since they are now over-the-counter, they can be used at any time. Also, ...

Read more

Hugging Patients During a Pandemic

Beth Sandy, MSN, CRNP Beth Sandy, MSN, CRNP

Read more

COVID-19 and Caring for Cancer Patients

Avani Yenamandra, PharmD Avani Yenamandra, PharmD

Coronaviruses are a large family of viruses that are common in people and animals. SARS-CoV-2, a novel coronavirus, causes a respiratory disease called coronavirus disease 2019, abbreviated COVID-19.1,2 Immunocompromised patients, especially those who have cancer and undergoing treatment, pose to ...

Read more

Mobocertinib, a First-In-Class Oral Therapy for EGFR Exon 20 Insertion-Positive NSCLC

Christian Watts Pharm.D., MSHI Candidate, Larry Buie Pharm.D., BCOP, FCCP, FASHP, Beth Sandy, MSN, CRNP Christian Watts Pharm.D., MSHI Candidate, Larry Buie Pharm.D., BCOP, FCCP, FASHP, Beth Sandy, MSN, CRNP

 

Read more

Cancer-related Fatigue After Receiving Chemotherapy Treatment: Should Additional Pharmacologic Recommendations Be Considered?

Amari Marshall & Abigail Shockley, PharmD Amari Marshall & Abigail Shockley, PharmD

According to the American Cancer Society, between 80 and 100% of patients with cancer report fatigue.1 Fatigue can be present while receiving active anticancer treatment and can persist for as long as 12 months after treatment cessation. In 2000, the National Comprehensive Cancer Network (NCCN) ...

Read more

Fam-Trastuzumab Deruxtecan (Enhertu) for HER 2 Amplified Gastric Adenocarcinoma

Christina Bartholomew Christina Bartholomew

Although treatment strategies for patients with metastatic gastric cancer who have failed prior lines of therapy remain limited, novel agents such as trastuzumab deruxtecan (Enhertu), provide further options for patients with HER2-positive disease.

Read more